Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 250

1.

Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.

Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D.

J Pharmacol Exp Ther. 2000 Nov;295(2):614-20.

2.
3.

Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.

Caballero R, Delpón E, Valenzuela C, Longobardo M, González T, Tamargo J.

Mol Pharmacol. 2001 Apr;59(4):825-36.

4.

Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.

Moreno I, Caballero R, González T, Arias C, Valenzuela C, Iriepa I, Gálvez E, Tamargo J, Delpón E.

J Pharmacol Exp Ther. 2003 Feb;304(2):862-73.

5.

Cocaine blocks HERG, but not KvLQT1+minK, potassium channels.

Zhang S, Rajamani S, Chen Y, Gong Q, Rong Y, Zhou Z, Ruoho A, January CT.

Mol Pharmacol. 2001 May;59(5):1069-76.

6.

The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.

Rampe D, Murawsky MK, Grau J, Lewis EW.

J Pharmacol Exp Ther. 1998 Aug;286(2):788-93.

7.

Open channel block of HERG K(+) channels by vesnarinone.

Kamiya K, Mitcheson JS, Yasui K, Kodama I, Sanguinetti MC.

Mol Pharmacol. 2001 Aug;60(2):244-53.

8.

Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

Kang J, Wang L, Chen XL, Triggle DJ, Rampe D.

Mol Pharmacol. 2001 Jan;59(1):122-6.

9.

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.

Kongsamut S, Kang J, Chen XL, Roehr J, Rampe D.

Eur J Pharmacol. 2002 Aug 16;450(1):37-41.

PMID:
12176106
10.

Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline.

Jo SH, Youm JB, Lee CO, Earm YE, Ho WK.

Br J Pharmacol. 2000 Apr;129(7):1474-80.

12.

High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide.

Kang J, Wang L, Cai F, Rampe D.

Eur J Pharmacol. 2000 Mar 31;392(3):137-40.

PMID:
10762666
13.
14.

Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.

Paul AA, Witchel HJ, Hancox JC.

Biochem Biophys Res Commun. 2001 Feb 9;280(5):1243-50.

PMID:
11162661
15.

QT interval prolongation and cardiac risk assessment for novel drugs.

Picard S, Lacroix P.

Curr Opin Investig Drugs. 2003 Mar;4(3):303-8. Review.

PMID:
12735231
16.

KvLQT1 modulates the distribution and biophysical properties of HERG. A novel alpha-subunit interaction between delayed rectifier currents.

Ehrlich JR, Pourrier M, Weerapura M, Ethier N, Marmabachi AM, Hébert TE, Nattel S.

J Biol Chem. 2004 Jan 9;279(2):1233-41.

17.

The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.

Suessbrich H, Schönherr R, Heinemann SH, Attali B, Lang F, Busch AE.

Br J Pharmacol. 1997 Mar;120(5):968-74.

18.

Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.

Kiehn J, Thomas D, Karle CA, Schöls W, Kübler W.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Mar;359(3):212-9.

PMID:
10208308
19.

Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.

Mohammad S, Zhou Z, Gong Q, January CT.

Am J Physiol. 1997 Nov;273(5 Pt 2):H2534-8.

20.

Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.

Potet F, Bouyssou T, Escande D, Baró I.

J Pharmacol Exp Ther. 2001 Dec;299(3):1007-12.

Items per page

Supplemental Content

Support Center